 Adrenergic Agonists
"Adrenergic Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to and activate adrenergic receptors.
| Descriptor ID |
D000322
|
| MeSH Number(s) |
D27.505.519.625.050.100 D27.505.696.577.050.100
|
| Concept/Terms |
Adrenergic Agonists- Adrenergic Agonists
- Agonists, Adrenergic
- Receptor Agonists, Adrenergic
- Adrenomimetics
- Adrenergic Agonist
- Agonist, Adrenergic
- Adrenergic Receptor Agonists
- Agonists, Adrenergic Receptor
- Adrenergic Receptor Agonist
- Agonist, Adrenergic Receptor
- Receptor Agonist, Adrenergic
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic Agonists".
This graph shows the total number of publications written about "Adrenergic Agonists" by people in this website by year, and whether "Adrenergic Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 3 | 0 | 3 | | 1994 | 0 | 1 | 1 | | 1999 | 1 | 0 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 0 | 1 | 1 | | 2006 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenergic Agonists" by people in Profiles.
-
Ostrin LA, Glasser A. Autonomic drugs and the accommodative system in rhesus monkeys. Exp Eye Res. 2010 Jan; 90(1):104-12.
-
Desai AN, Salim S, Standifer KM, Eikenburg DC. Involvement of G protein-coupled receptor kinase (GRK) 3 and GRK2 in down-regulation of the alpha2B-adrenoceptor. J Pharmacol Exp Ther. 2006 Jun; 317(3):1027-35.
-
Desai AN, Standifer KM, Eikenburg DC. Simultaneous alpha2B- and beta2-adrenoceptor activation sensitizes the alpha2B-adrenoceptor for agonist-induced down-regulation. J Pharmacol Exp Ther. 2004 Nov; 311(2):794-802.
-
Baker JG, Hall IP, Hill SJ. Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses. Mol Pharmacol. 2003 Sep; 64(3):679-88.
-
Shivachar AC, Eikenburg DC. Differential effects of epinephrine and norepinephrine on cAMP response and g(i3)alpha protein expression in cultured sympathetic neurons. J Pharmacol Exp Ther. 1999 Oct; 291(1):258-64.
-
Jacinto SM, Lokhandwala MF, Jandhyala BS. Studies on the pharmacological interventions to prevent oxygen free radical (OFR)-mediated toxicity; effects of dopexamine, a DA1 receptor and beta 2 adrenoceptor agonist. Naunyn Schmiedebergs Arch Pharmacol. 1994 Sep; 350(3):277-83.
-
Lokhandwala MF, Hegde SS. Cardiovascular pharmacology of adrenergic and dopaminergic receptors: therapeutic significance in congestive heart failure. Am J Med. 1991 May 29; 90(5B):2S-9S.
-
Vyas SJ, Apparsundaram S, Ricci A, Amenta F, Lokhandwala MF. Biochemical, autoradiographic and pharmacological evidence for the involvement of tubular DA-1 receptors in the natriuretic response to dopexamine hydrochloride. Naunyn Schmiedebergs Arch Pharmacol. 1991 Jan; 343(1):21-30.
-
Amenta F, Ricci A, Napoleone P, Vyas SJ, Lokhandwala MF. Anatomical localization of the binding and functional characterization of responses to dopexamine hydrochloride in the rat mesenteric vasculature. Pharmacology. 1991; 42(4):211-22.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|